Figure 1

Figure 1

Average MDS-UPDRS scores from baseline (Day 0) to 12 months (Day 360) in all participants who completed dosing regimen by August 31, 2026, and had evaluable MDS-UPDRS scores at each time point

Format

PNG

Source

Gain Therapeutics, Inc.

Téléchargements